Clinical Trial

Treating Obsessive-Compulsive Disorder with Ketamine

Study Description

Understanding How Ketamine Brings About Rapid Improvement in OCD

The purpose of this study is to understand how ketamine brings about rapid improvement in Obsessive-Compulsive Disorder (OCD) symptoms.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Ketamine

OCD patients in this arm will receive 0.5mg/kg of ketamine - one single infusion

Drug - Midazolam

OCD patients in this arm will receive 0.045mg/kg of midazolam - one single infusion

Additional Information

Official Study Title

NMDAR Modulation As a Therapeutic Target and Probe of Neural Dysfunction in OCD

Clinical Trial ID

NCT02624596

ParticipAid ID

xbo8kd